4th Translational Research Conference: Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia

4^th Translational Research Conference:
Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia

March 14-16, 2025 – Malahide (Dublin), Ireland

#ESHERYTHRO2025

Chairs: Maria-Domenica Cappellini, Michaela Fontenay, Alexis A. Thompson

REGISTRATION AND ABSTRACT SUBMISSION ARE OPEN!

SCIENTIFIC TOPICS:
– Update on pathophysiology on sickle cell disease, thalassemia and normal red blood cell
– Iron and erythropoiesis
– Inflammation in sickle cell disease
– Dyserythopoiesis in thalassemia
– Premature aging in sickle cell and thalassemia
– Fetal hemoglobin control
– Novel pharmacologic approaches to sickle cell disease and thalassemia
– Novel genomic approaches to sickle cell and thalassemia
– Cases discussions

LEARNING OBJECTIVES:
Upon completion of this CME activity, participants will learn about:
– Increasing our understanding of regulatory mechanisms of erythropoiesis
– Post-transcriptional regulation of erythropoiesis
– Listing the causes of ineffective erythropoiesis and the potential targets for innovative treatments

THE PROGRAMME WILL INCLUDE:
– Plenary Sessions
– Simultaneous Meet the Experts Sessions
– Round Table Discussions
– Poster Presentations
– Short Oral Communications
– Ample time for in-depth discussion

This meeting will be valuable to you if you are looking for:
– A cutting-edge scientific program – from basic science to clinical and therapeutic applications and perspectives
– Multiple opportunities for scientific interaction with an international faculty of distinguished experts
– An emphasis on critical discussion
The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and insight in controversies in the field.

Click HERE to read the preliminary programme!

DEADLINE FOR SUBMISSION OF ABSTRACTS FOR BRIEF ORAL COMMUNICATIONS OR POSTER PRESENTATIONS: December 15^th, 2024

CLICK HERE TO SUBMIT YOUR ABSTRACT

Abstracts guidelines:
– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)
– Maximum number of words: 500
– Your abstract will be submitted to the peer review procedure.
The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).

We accept “encore” abstract.

Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

Grand Hotel Malahide
Grove Road, Malahide, K36XT65 Dublin, Ireland

With the support of*:

Level 2 Conference Partner

*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

The registration fee for the ESH 4^th Translational Research Conference: Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia is:
– 600€ for fully trained
– 300€ for in-training *
– 300€ Allied Health Professionals
– 600€ for Corporate
*A proof will be requested to confirm your status.

ESH is pleased to offer BSH, DGHO and PTHiT Members a 20% discount on the conference registration fees.

This fee includes:
– Your seat in the Conference Room
– The conference materials,
– Welcome cocktail, luncheons, refreshments throughout the conference.
Your seat in the conference will be definitively reserved upon receipt of your fee.

Cancellation policy of registration fee:
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.

REGISTER HERE